Global 3D bioprinting market is expected to reach USD 1.82 billion by 2022

Global 3D bioprinting market is expected to reach USD 1.82 billion by 2022, according to a new report by Grand View Research Inc.

Rising prevalence of chronic diseases such as Chronic Kidney Disease (CKD) which demands kidney transplantation is expected to boost the market growth, as 3D bioprinting is convenient and cost effective substitute for organ transplantation.

Emerging medical applications of 3D bioprinting such as toxicity testing, drug discovery, tissue engineering and consumer product testing are expected to further drive the market growth positively. Increasing R&D expenditure is anticipated to be high impact rendering driver for the industry. 3D bioprinting advances in tissue engineering and allows developments to be done using biomaterials which have better biocompatibility. Moreover, rising geriatric population is expected to assist the market growth, as this demographic is highly susceptible to age related organ deformities.Read more

Source: prnewswire.com; image: northyorkliving.com